Amgen Inc., AMGN is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Amgen Inc., AMGN has a market cap of 127715.06. Since its IPO date on the 9/7/1984, Amgen Inc., AMGN performance year to date is 6.80%. Today Amgen Inc., AMGN has gained -0.41%, with a current price of 170.06.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 81.20%. The management of the company have seen the company have a payout ratio of 36.30%. Return of assets are at 10.10%, with return on investment at 12.50%.
In terms of debt levels and profit levels, Amgen Inc., AMGN is seeing a long-term debt/equity of 0.93. While Total debt/equity is 1.1. With a profit margin of 33.10%, this is combined with a gross margin of 81.40%, and operating margin of 40.70%. Amgen Inc. ability to meet debt levels, with a current ratio of 4, while the quick ratio is 3.7.
For the last year Amgen Inc., AMGN has seen a EPS growth of 35.20%. A performance for the year of 18.17%. The 52-week high is -3.73%, and the 52-week low is 33.95%. The average volume for Amgen Inc., AMGN is 2935300.
With a target price of 191, can Amgen Inc., AMGN reach this target? Looking at the value indicators of Amgen Inc., AMGN. Amgen Inc. has a P/E of 17.4 and a forward P/E of 13.63. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.05. Amgen Inc. also has a P/S and a P/B of 5.68 and 4.24 respectively. For P/cash, Amgen Inc. has a value of 3.65, while it is 21.34 for P/free cash flow.
At the current price of 170.06, Amgen Inc. has a dividend yield of 2.35%. We see a return on equity of 25.90%.
Looking more long-term Amgen Inc., is projected to get an EPS growth for the next five years of 8.48%. In the short-term an EPS growth of 9.84% in the next year is forecasted. This is after a EPS growth of 35.20% for this year and for the last five years a 13.60% growth has been seen.